Chordoma Family StudyProton Beam Therapy for Chordoma PatientsProton Radiation for Chordomas and ChondrosarcomasQUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasStereotactic Body Radiotherapy for Spine TumorsHigh Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of SkullNivolumab and Relatlimab in Treating Participants With Advanced ChordomaBN Brachyury and Radiation in ChordomaGenetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma FamiliesNilotinib With Radiation for High Risk ChordomaTazemetostat Expanded Access Program for Adults With Solid TumorsStudy of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent ChordomaPemetrexed for the Treatment of ChordomaGenetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility GenesSacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized DiseaseChildren and Adults With ChordomaA Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial SarcomaQUILT-3.011 Phase 2 Yeast-Brachyury Vaccine ChordomaIon Irradiation of Sacrococcygeal ChordomaTrial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull BaseHSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsCollecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaProton Therapy for Chordomas and/or ChondrosarcomasHypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With ChordomasCharged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical SpineA Study of IMRT in Primary Bone and Soft Tissue SarcomaStereotactic Body Radiotherapy for Head and Neck TumorsTrial of Dasatinib in Advanced SarcomasPolyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With CancerEfficacy and Safety of Imatinib in ChordomaAmifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsCDK4/6 Inhibition in Locally Advanced/Metastatic ChordomaAfatinib in Locally Advanced and Metastatic ChordomaNivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic ChordomaA Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic ChordomaRandomized Carbon Ions vs Standard Radiotherapy for Radioresistant TumorsImprovement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT TracersBLESSED: Expanded Access for DeltaRex-G for Advanced Solid Tumors, Lymphoma and Multiple Myeloma
P1050
P2293
P5166
Combined use of maxillomandibular swing approach and neurosurgical ultrasonic aspirator in the management of extensive clival chordoma: a case reportDetection and distribution of the carbohydrate binding protein galectin-3 in human notochord, intervertebral disc and chordomaChordoma and chondrosarcoma gene profile: implications for immunotherapyPotential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayIdentification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formationFrequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationAberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomasPaediatric ChordomasResolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cellsImmunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordomaChordoma: current concepts, management, and future directionsChordoma: the nonsarcoma primary bone tumorSacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2Operative management of sacral chordomaImatinib mesylate in chordomaBrachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomasA novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyExtended ultrastructural characterization of chordoma cells: the link to new therapeutic optionsCombined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in ChordomaSkull base chordomas: overview of disease, management options, and outcome.Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas.MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.Identification of repurposed small molecule drugs for chordoma therapy.The role of Gamma Knife surgery in the treatment of skull base chordomas.Chordoma of the petrous bone.Diagnosis and treatment of chordoma.Fatal acute pontocerebellar hemorrhage due to an unsuspected spheno-occipital chordoma.Chordomas and chondrosarcomas involving the cavernous sinus: review of surgical treatment and outcome in 31 patients.Clinical and radiological presentations of pelvic parachordomaIntradural retroclival chordomaBenign and malignant chordomas; a clinico-anatomical study of twenty-two casesSurgical management of petroclival chordomas: report of eight cases.Comprehensive review of intracranial chordoma.[Clinical and pathological study of chordoma in the skull base].Intracranial chordoma presenting as acute hemorrhage in a child: Case report and literature review.Relations between subcellular events in the degenerating notochord and histopathological features of the spinal chordomas.Metastatic saccrococcygeal chordoma.[Usefulness of neuroendoscopy and a neuronavigator for removal of clival chordoma]Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literatureCarbon ion radiation therapy for chordomas and low grade chondrosarcomas--current status of the clinical trials at GSI.
P921
Q61865134-9AFA2DB5-747C-4899-85EF-59A232CE735DQ61917513-264B2CBC-97A0-4726-A88F-1C6D8F3E276BQ61967642-F640AEAD-E13C-4EBA-928F-947BF4BA7D94Q62025671-697F8285-8495-4AA5-BB8D-0952EF27B95DQ63318137-3CB417EF-5472-4CB9-B916-55277EEBF80CQ63335811-FDD19384-910B-49A3-B923-CB24BDCD02B4Q63336184-9117D369-EECF-4573-9508-202BBD2EB3D4Q63393842-09B301E5-B23F-47F6-A420-C3CC276D48B2Q63394727-5ABFE071-3AFD-459F-BF0D-08C8DBC35FE3Q63573812-7027BCA6-08EE-4626-9AC8-EB1FA562C70FQ63806713-F354E6E2-209D-44DF-B958-27504949050FQ63808665-530C239C-85D2-4E2D-BB56-6252E4DFBE09Q63830252-A62EDF21-BE0A-42BE-82ED-6B6E570362B5Q64121225-059F3EC6-F197-4ED0-8A87-208E6C1F51A5Q64123619-FB4AEC16-E76B-4802-BFBD-69AD105F5FA1Q64140072-6CE0C6C9-0A07-4B5E-B266-8805FD76448DQ64186101-AB2F7FED-F806-44FD-8E29-1B496256EE28Q64188955-C959B635-A090-4C21-8175-5DDAA5BB9180Q64398065-60396F8E-2E86-41A7-AC43-C6853A66C74BQ64626201-0D87F3E5-A6A2-495F-B5A4-56E0EB270B26Q64654354-467BE6A6-45AF-4140-91E1-953B0C6680C2Q64673627-6CFEBD31-A8F4-4E3E-9FCF-DEF122AE052AQ64676931-DD26AA89-077A-4463-9EC3-F2677F0FA95BQ64709316-8AB39A9B-1C57-4035-9D95-BBB384E89C0BQ64719233-3F8CA7C4-8877-476B-B007-9822AA27A097Q64725014-ED0CBB2D-D372-4DEC-92BF-C67FFB4F07A5Q65339903-28D5710A-4B52-437D-9CB8-C18C6B68C06EQ65376199-EFF3B83B-1C32-4294-8BC9-54FA9FE9A32EQ65383728-23295A7A-A95A-4BE5-B09B-557CC957E8A7Q65388322-F38644A3-547D-4EE5-B7E3-9E357A93B6C5Q66028729-93F808A7-F861-4294-A7B6-82C4CEE6D149Q66036570-B8EA9B86-C78C-4328-B8F7-CA7D10C47412Q66047043-E42D0CE6-4DB8-4A8F-A74E-5F4FD9ABAAD0Q66072566-A89E1559-C3A5-491A-8A5F-6D2128D9398AQ66076175-7F015DF0-F458-408B-9CFC-3F93A0FD5CD7Q66080184-BC967E73-1272-47ED-A297-BCE5FD7B5BE6Q66388652-5E627647-921E-4017-BE6F-9747AA840454Q66399247-37B85086-64D6-4662-B75C-8511F534647EQ66400879-CB033CB5-3B4D-43F4-BAA2-83F4F44B2D0DQ74281458-6A3CD410-E80C-4E7E-95B9-9DEA6ACFF071
P1050
description
Krankheit
@de
notochordal cancer that derives from cellular remnants of the notochord
@en
tumeurs malignes
@fr
name
Chordom
@de
Chordoma
@hu
Cordoma
@es
Struniak
@pl
chordoma
@en
chordome
@fr
cordoma
@ca
cordoma
@it
cordoma
@pt
Хордома
@ru
type
label
Chordom
@de
Chordoma
@hu
Cordoma
@es
Struniak
@pl
chordoma
@en
chordome
@fr
cordoma
@ca
cordoma
@it
cordoma
@pt
Хордома
@ru
altLabel
CHDM
@en
CHORDOMA, MALIGNANT
@en
CHORDOMA, SUSCEPTIBILITY TO
@en
CHORDOMA, SUSCEPTIBILITY TO; CHDM
@en
Chordoma
@pl
Notochordal sarcoma
@en
chordoma
@en
notochordoma
@en
notocordoma
@ca
susceptibility to chordoma
@en
prefLabel
Chordom
@de
Chordoma
@hu
Cordoma
@es
Struniak
@pl
chordoma
@en
chordome
@fr
cordoma
@ca
cordoma
@it
cordoma
@pt
Хордома
@ru
P2888
P673
P486
P6366
P646
P672
P1748
P1995
P2293
P2892
P31
P373
P3827
P3841
HP:0010762